Prescription drugs are considered defective if there are not sufficient warnings to accompany the drug strongly advising that the drug can cause certain symptoms and/or side effects. This ability to recover for defective product/drugs has been substantially reduced by the drug industry’s new policy of extensively advertising the potential adverse effects of a product/drug on television, in magazines and in newspaper articles. This new tactic by the drug industry has virtually eliminated defective product cases involving drugs that fail to warn of their potentially hazardous repercussions.
